BDBM50312873 4-(4-(pyridin-2-yl)thiazol-2-ylamino)phenol::4-{[4-(2-Pyridinyl)-1,3-thiazol-2-yl]amino}phenol::CHEMBL579212::cid_704363
SMILES: Oc1ccc(Nc2nc(cs2)-c2ccccn2)cc1
InChI Key: InChIKey=GLAADHPXEHHDBC-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valosin containing protein, p97 subunit (Homo sapiens (Human)) | BDBM50312873 (4-(4-(pyridin-2-yl)thiazol-2-ylamino)phenol | 4-{[...) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Myriad Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Inhibition of VCP assessed as conversion of ATP to ADP by enzyme coupled glucokinase assay | Bioorg Med Chem Lett 20: 1677-9 (2010) Article DOI: 10.1016/j.bmcl.2010.01.058 BindingDB Entry DOI: 10.7270/Q2CJ8DMM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
nuclear receptor subfamily 4, group A, member 1 (Homo sapiens (Human)) | BDBM50312873 (4-(4-(pyridin-2-yl)thiazol-2-ylamino)phenol | 4-{[...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | PCBioAssay | n/a | n/a | n/a | n/a | 3.69E+3 | n/a | n/a | n/a | n/a |
Sanford-Burnham Center for Chemical Genomics Curated by PubChem BioAssay | Assay Description Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBMRI, San Diego, C... | PubChem Bioassay (2008) BindingDB Entry DOI: 10.7270/Q2R78CMH | |||||||||||
More data for this Ligand-Target Pair |